Medtronic PLC (MDT): Price and Financial Metrics

Medtronic PLC (MDT): $82.75

-0.01 (-0.01%)

POWR Rating

Component Grades








Add MDT to Watchlist
Sign Up

Industry: Medical - Devices & Equipment




#5 of 140

in industry

MDT Price/Volume Stats

Current price $82.75 52-week high $98.89
Prev. close $82.76 52-week low $75.76
Day low $82.44 Volume 6,588,200
Day high $83.25 Avg. volume 6,248,399
50-day MA $84.98 Dividend yield 3.34%
200-day MA $83.45 Market Cap 110.09B

MDT Stock Price Chart Interactive Chart >


  • MDT scores best on the Stability dimension, with a Stability rank ahead of 81.66% of US stocks.
  • MDT's strongest trending metric is Growth; it's been moving up over the last 179 days.
  • MDT ranks lowest in Momentum; there it ranks in the 64th percentile.

MDT Stock Summary

  • With a market capitalization of $116,398,770,213, MEDTRONIC PLC has a greater market value than 98.35% of US stocks.
  • MDT's went public 37.42 years ago, making it older than 93.61% of listed US stocks we're tracking.
  • In terms of volatility of its share price, MDT is more volatile than merely 3.51% of stocks we're observing.
  • Stocks that are quantitatively similar to MDT, based on their financial statements, market capitalization, and price volatility, are HON, EW, PH, OTIS, and IBM.
  • Visit MDT's SEC page to see the company's official filings. To visit the company's web site, go to

MDT Valuation Summary

  • In comparison to the median Healthcare stock, MDT's price/sales ratio is 72.73% higher, now standing at 3.8.
  • Over the past 243 months, MDT's price/sales ratio has gone down 4.3.

Below are key valuation metrics over time for MDT.

Stock Date P/S P/B P/E EV/EBIT
MDT 2023-05-23 3.8 2.3 28.5 23.3
MDT 2023-05-22 3.9 2.3 29.3 23.9
MDT 2023-05-19 3.9 2.3 29.3 23.8
MDT 2023-05-18 3.8 2.3 29.1 23.7
MDT 2023-05-17 3.8 2.3 29.0 23.6
MDT 2023-05-16 3.8 2.3 29.1 23.7

MDT Growth Metrics

    Its 5 year net income to common stockholders growth rate is now at 18.89%.
  • Its 5 year revenue growth rate is now at -2.68%.
  • Its 3 year revenue growth rate is now at 3.69%.
MDT's revenue has moved down $789,000,000 over the prior 15 months.

The table below shows MDT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 30,808 6,290 4,321
2022-06-30 31,070 7,137 5,205
2022-03-31 31,686 7,346 5,039
2021-12-31 31,785 7,034 4,914
2021-09-30 31,797 7,162 4,704
2021-06-30 31,597 7,254 3,882

MDT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MDT has a Quality Grade of C, ranking ahead of 63.82% of graded US stocks.
  • MDT's asset turnover comes in at 0.334 -- ranking 125th of 186 Medical Equipment stocks.
  • XRAY, BAX, and PEN are the stocks whose asset turnover ratios are most correlated with MDT.

The table below shows MDT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-30 0.334 0.665 0.104
2021-04-30 0.317 0.652 0.102
2021-01-29 0.296 0.639 0.076
2020-10-30 0.299 0.646 0.086
2020-07-31 0.303 0.658 0.097
2020-04-24 0.316 0.674 0.116

MDT Price Target

For more insight on analysts targets of MDT, see our MDT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $145.56 Average Broker Recommendation 1.47 (Moderate Buy)

Medtronic PLC (MDT) Company Bio

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US. In 2015, Medtronic acquired Irish–tax registered Covidien (a U.S. tax inversion to Ireland from 2007), in the largest U.S. corporate tax inversion in history, which enabled Medtronic to move its legal registration from the U.S. to Ireland. Medtronic operates in 140 countries and employs over 104,950 people. (Source:Wikipedia)

MDT Latest News Stream

Event/Time News Detail
Loading, please wait...

MDT Latest Social Stream

Loading social stream, please wait...

View Full MDT Social Stream

Latest MDT News From Around the Web

Below are the latest news stories about MEDTRONIC PLC that investors may wish to consider to help them evaluate MDT as an investment opportunity.

The 3 Best Income Stocks to Buy in a Rising-Interest-Rate Scenario

Traders are bored with Treasuries and demand more risk, but still prefer stability.

Jeremy Flint on InvestorPlace | May 23, 2023

Medtronic's EV ICD System Proves Effective in Cardiac Arrhythmia Management: Long-term Study Results

Medtronic plc (NYSE: MDT) announced longer-term follow-up results of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) System, designed to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest, including patients followed through an average of 17.1 months. Medtronic says its EV ICD system is a first-of-its-kind implantable defibrillator designed to avoid certain risks of traditional, transvenous ICDs because its lead (thin wire) is placed out

Yahoo | May 22, 2023

Medtronic Extravascular ICD global clinical trial results reinforce device safety and effectiveness

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced longer-term follow-up results of its investigational EV ICD™ System, designed to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest. Findings from the Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Study, including patients followed through an average of 17.1 months, were presented as late-breaking science at Heart Rhythm 2023 in New Orleans. The EV ICD system is investi

Yahoo | May 20, 2023

Medtronic Designated as a "3+" Company in the 50/50 Women on Boards Gender Diversity Directory(TM)

Medtronic is now designated as a "3+" company in the 50/50 Women on Boards Gender Diversity Directory™.

Yahoo | May 19, 2023

What's in the Cards for Medtronic (MDT) in Q4 Earnings?

Medtronic (MDT) is likely to have prioritized its R&D investments, which might get reflected in the fiscal Q4 results.

Yahoo | May 19, 2023

Read More 'MDT' Stories Here

MDT Price Returns

1-mo -8.76%
3-mo 0.06%
6-mo 5.76%
1-year -13.17%
3-year -8.06%
5-year 6.33%
YTD 7.39%
2022 -22.55%
2021 -9.79%
2020 5.70%
2019 27.34%
2018 15.18%

MDT Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MDT Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!